Does your underarm sweating bother you?

Do you feel like your underarms are always sweaty, soaking through clothing or are you uncomfortable with the amount of sweat you produce? You may have a treatable condition called axillary hyperhidrosis, which means excessive sweating of the underarms. Some people experience hyperhidrosis on their underarms while others experience it on their palms of their hands or soles of their feet or even the scalp. The extra moisture in the area can not only affect day to day activities but can sometimes make individuals very self-conscious. There are treatment options for hyperhidrosis from OTC or prescription topicals to injections of Botox, which helps to temporarily weaken the muscles that cause sweating. Botox treatment is an in-office procedure that involves small pricks of a needle and injection of Botox into the skin throughout the underarm area and in about a week time, one should notice a decrease in the amount of sweat produced in the area. The treatment usually lasts about 5-6 months and, in some patients, can last longer. For many patients who feel they sweat more in the underarms than they want, this is an easy and effective treatment, and most are extremely happy and satisfied with the improvement they notice in their day to day lives.

Give us a call to find out more and schedule your consult at Lakeside Cosmetic Center: (585) 905-3414

Blog Written by: Eleni Filios, PA

Myth Buster: Chemical Peels in the Summer

What is the difference between facial fillers and BOTOX®?

This is a common question! BOTOX® is a purified neurotoxin. It is utilized to temporarily paralyze muscles in the face that are associated with wrinkling. Through deliberate and precise placement of BOTOX®, we are able to effectively soften moderate to severe wrinkles. Typical treatment areas include the glabella (the area between the eyebrows), the forehead, crowsfeet, bunny lines, vertical wrinkles around the lips, wrinkling of the chin, and more. Facial filler, on the other hand, is used to replace and restore volume in areas of loss. The most commonly used fillers these days are hyaluronic acid, a naturally occurring component of the skin. Commonly treated areas include the cheeks, nasolabial folds, marionette lines, tear troughs, and lips. Through careful and skillful placement of the filler, a softer, more rejuvenated look can be achieved.

What is Botox®?

Botox® (botulinum toxin type A) is a purified neurotoxin utilized to temporarily paralyze muscles in the face associated with moderate to severe wrinkling. It is a form of the same toxin produced by the microbe which causes Botulism. Although this can sound scary, the amount used to treat facial wrinkles is very minute and very safe. It works by causing a chemical denervation at the motor nerve terminals resulting in a reduction of muscular activity. It acts very locally and is not expected to be absorbed systemically. Botox® is now FDA approved for treatment of forehead lines, crow’s feet lines, and frown lines between the eyebrows. Utilized correctly and by an experienced provider, it can help create a softer, smoother, more rejuvenated look. Our motto is to only give you what you need and to stay away from the frozen or overdone look.

For more information, follow the attached link:

https://www.medicalnewstoday.com/articles/158647.php

Before – Day 1:

 

 

 

 

 

 

 

 

After – Day 7:

 

 

 

 

Important Botox® Information:

BCT110283_BTXC_HCP-ISI

BCT110378_v3_BTXC-Consumer-ISI

FINAL-FHL-PI-20171002-BOTOX-Cosmetic

BOTOX® Cosmetic (onabotulinumtoxinA) Important Information

Indications

BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of: – moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity – moderate to severe lateral canthal lines associated with orbicularis oculi activity – moderate to severe forehead lines associated with frontalis activity

IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING

WARNING: DISTANT SPREAD OF TOXIN EFFECT

Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.

CONTRAINDICATIONS BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.

WARNINGS AND PRECAUTIONS Lack of Interchangeability between Botulinum Toxin Products

The potency Units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.

Spread of Toxin Effect Please refer to Boxed Warning for Distant Spread of Toxin Effect. No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported.

Serious Adverse Reactions With Unapproved Use Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.

Hypersensitivity Reactions Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.

Cardiovascular System There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.

Increased Risk of Clinically Significant Effects with Pre-existing Neuromuscular Disorders Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).

Dysphagia and Breathing Difficulties Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).

Pre-existing Conditions at the Injection Site Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).

Human Albumin and Transmission of Viral Diseases This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.

ADVERSE REACTIONS The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for glabellar lines was eyelid ptosis (3%).

The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).

The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%) and eyelid ptosis (2%).

DRUG INTERACTIONS Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.

The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.

Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.

USE IN SPECIFIC POPULATIONS There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.

Please see BOTOX® Cosmetic Full Prescribing Information including Boxed Warning and Medication Guide.

What is Facial Plastic and Reconstructive Surgery?

Facial Plastic and Reconstructive Surgery is a surgical specialty focused on treating the functional and cosmetic physical defects of the head and neck. Typically, a Facial Plastic Surgeon has undergone rigorous training that includes 4 years of medical school, followed by 5 years of residency in Otolaryngology – Head and Neck Surgery, and 1 year of fellowship in Facial Plastic Surgery. This means that a Facial Plastic Surgeon’s surgical training is focused solely on the intricate anatomy of the head and neck.

Some procedures performed by these Surgeons include:

  • Upper and lower eyelid blepharoplasty
  • Browlift
  • Chin augmentation
  • Earlobe repair
  • Earlobe reduction
  • Fat transfer to restore volume to the face
  • Facelift
  • Neck-lift
  • Otoplasty
  • Rhinoplasty
  • Skin cancer treatment and repair
  • Facial trauma

Non-surgical rejuvenation of the face is also an important aspect of a Facial Plastic Surgeon’s practice. Usualy this involves an emphasis on skin care, using laser, chemical peels, etc, as well as the use of botox and fillers to restore and rejuvenate the face.